Liver Disease Treatment Market COVID-19 Impact Analysis, by Treatment Type (Immunosuppressants, Antiviral Drugs, Immunoglobulins, Vaccines, Targeted Therapy, Corticosteroids, Chemotherapy Drugs) and Disease Type (Autoimmune Diseases, Hepatitis, Non-alcoholic Fatty Liver Disease (NAFLD), Genetic Disorders, Cancer, and Others), By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
REPORT HIGHLIGHT
Liver Disease Treatment market size was valued at USD 22,300.42 Million in 2022, expanding at a CAGR of 6.42% from 2023 to 2030.
Treatment for liver disease refers to medical measures taken to control and lessen illnesses that have an impact on the structure or operation of the liver. Depending on the exact liver ailment, several treatment modalities are used, but they often entail modifying one\'s lifestyle, taking medications, and in extreme circumstances, undergoing surgery or a liver transplant. Hepatitis, cirrhosis, fatty liver disease, and liver cancer are examples of common liver illnesses. Controlling inflammation, treating symptoms, avoiding consequences, and addressing underlying causes are frequently the objectives of treatment. To improve results and maintain liver function, early diagnosis, and prompt treatments are essential.
Liver Disease Treatment Market Dynamics
- The rise in the number of people with liver diseases propelled the market growth
The increased prevalence of liver disorders, the rise in alcohol usage, and poor eating habits are the main factors anticipated to propel growth in the market for therapies for liver diseases. For instance, according to a research report that was published in the Clinical Liver Disease journal in June 2021, chronic liver disease (CLD), which affects nearly 1.5 billion people worldwide, is one of the major causes of sickness and mortality globally. Furthermore, according to research published in June 2021 by the American Association for the Study of Liver Diseases, non-alcoholic fatty liver disease (NAFLD) is the leading cause of hepatic illness, accounting for 59% of cases, followed by hepatitis C (9%), hepatitis B (29%), and alcoholic liver disease (ALD) (2%). Furthermore, a research published in Clinical and Molecular Hepatology in October 2022 predicted that by 2040, the prevalence of non-alcoholic fatty liver disease (NAFLD) will be 55.7% worldwide. As a result, rising liver ailments have fueled the industry as a whole.
Liver Disease Treatment Market- Key Insights
- As per the analysis shared by our research analyst, the Global Liver Disease Treatment market is estimated to grow annually at a CAGR of around 6.42% over the forecast period (2023-2030)
- The Liver Disease Treatment market is projected to grow at a significant rate due to the rise in the number of people with liver diseases to propel the market growth
- Based on Treatment Type segmentation, Antiviral Drugs was predicted to show maximum market share in the year 2022
- Based on Disease Type segmentation, Hepatitis was the leading Disease Type in 2022
- On the basis of region, North America was the leading revenue generator in 2022
Liver Disease Treatment Market- Segmentation Analysis:
The Global Liver Disease Treatment market is segmented on the basis of Type, Disease Type, and Region.
The market is divided into categories based on Type: Immunosuppressants, Antiviral Drugs, Immunoglobulins, Vaccines, Targeted Therapy, Corticosteroids, and Chemotherapy Drugs. Positive effects are being produced on the antiviral drug\'s sub-segment by the significantly increasing expenditures in the sector, largely because of its numerous advantages. Additionally, rising healthcare costs, increased public awareness, and an increase in the prevalence of hepatitis B and C are other significant aspects anticipated to support market expansion.
The market is divided into categories based on Disease Type: Autoimmune Diseases, Hepatitis, Non-alcoholic Fatty Liver Disease (NAFLD), Genetic Disorders, Cancer, and Others. Due to pharmaceutical mistakes, excessive alcohol intake, autoimmune disorders, viral infections, and nonalcoholic steatohepatitis, the inflammatory status of the liver tissue has significantly worsened during the past several years.
Liver Disease Treatment Market- Geographical Insights
Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. North America region is expected to grow. In 2022, the market for Liver Disease Treatments will be dominated by North America. The extensively increasing need for advanced and innovative liver disease therapeutics particularly in China, India, and South Korea is one of the key elements boosting the development of the industry. Also, one of the major factors behind this growth can be the increasing prevalence of NAFLD and hepatitis, lack of expertise, and the poor healthcare infrastructure in the region.
Liver Disease Treatment Market- Competitive Landscape:
Companies sell their products through a variety of channels, including corporate websites, e-commerce websites, retailers, distributors, and end consumers. Products makers compete on a variety of aspects, including product costs, performance, product making, technology, reputation, and availability. Some of the primary Types used by corporations to strengthen their reach and expand their market share include new product launches, distribution network development, R&D spending, and mergers and acquisitions. For instance, in January 2023, Topline data from the Phase 2 SEQUOIA clinical research of experimental Fazirsiran for the treatment of liver disease linked to alpha-1 antitrypsin deficiency (AATD-LD) were released by Takeda and Arrowhead Pharmaceuticals Inc.
Recent Developments:
- In January 2022, Based on its second confirmatory research, Merck\'s medication Keytruda was granted conditional approval as a therapy for liver cancer. In Asia, Keytruda reduced the risk of mortality in individuals with hepatocellular carcinoma by 21% compared to placebo.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL LIVER DISEASE TREATMENT MARKET KEY PLAYERS
- Vertex Pharmaceuticals
- Takeda Pharmaceuticals
- Shire (now part of Takeda Pharmaceuticals)
- Roche
- Pfizer
- Novartis
- Madrigal Pharmaceuticals
- Intercept Pharmaceuticals
- Gilead Sciences
- Genfit
- Durect Corporation
- Conatus Pharmaceuticals
- Bristol-Myers Squibb
- Alnylam Pharmaceuticals
- Allergan
GLOBAL LIVER DISEASE TREATMENT MARKET, BY TREATMENT TYPE
- Immunosuppressants
- Antiviral Drugs
- Immunoglobulins
- Vaccines
- Targeted Therapy
- Corticosteroids
- Chemotherapy Drugs
GLOBAL LIVER DISEASE TREATMENT MARKET, BY DISEASE TYPE
- Autoimmune Diseases
- Hepatitis
- Non-alcoholic Fatty Liver Disease (NAFLD)
- Genetic Disorders
- Cancer
- Others
GLOBAL LIVER DISEASE TREATMENT MARKET, BY REGION
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
Rest of MEA
TABLE OF CONTENT
1. Liver Disease Treatment Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Liver Disease Treatment Market Snippet by Treatment Type
2.1.2. Liver Disease Treatment Market Snippet by Disease Type
2.1.3. Liver Disease Treatment Market Snippet by Country
2.1.4. Liver Disease Treatment Market Snippet by Region
2.2. Competitive Insights
3. Semiconductor Memory Key Market Trends
3.1. Liver Disease Treatment Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Liver Disease Treatment Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Liver Disease Treatment Market Opportunities
3.4. Liver Disease Treatment Market Future Trends
4. Semiconductor Memory Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Liver Disease Treatment Market: COVID-19 Impact Analysis
5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
5.2.1. Top Performing Segments
5.2.2. Marginal Growth Segments
5.2.3. Top Looser Segments
5.2.4. Marginal Loss Segments
6. Liver Disease Treatment Market Landscape
6.1. Liver Disease Treatment Market Share Analysis, 2022
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Liver Disease Treatment Market – By Treatment Type
7.1. Overview
7.1.1. Segment Share Analysis, By Treatment Type, 2022 & 2030 (%)
7.1.2. Immunosuppressants
7.1.3. Antiviral Drugs
7.1.4. Immunoglobulins
7.1.5. Vaccines
7.1.6. Targeted Therapy
7.1.7. Corticosteroids
7.1.8. Chemotherapy Drugs
8. Liver Disease Treatment Market – By Disease Type
8.1. Overview
8.1.1. Segment Share Analysis, By Disease Type, 2022 & 2030 (%)
8.1.2. Autoimmune Diseases
8.1.3. Hepatitis
8.1.4. Non-alcoholic Fatty Liver Disease (NAFLD)
8.1.5. Genetic Disorders
8.1.6. Cancer
8.1.7. Others
9. Liver Disease Treatment Market– By Geography
9.1. Introduction
9.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
9.2. North America
9.2.1. Overview
9.2.2. Semiconductor Memory Key Manufacturers in North America
9.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
9.2.4. North America Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
9.2.5. North America Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
9.2.6. U.S.
9.2.6.1. Overview
9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.2.6.3. U.S. Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
9.2.6.4. U.S. Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
9.2.7. Canada
9.2.7.1. Overview
9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.2.7.3. Canada Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
9.2.7.4. Canada Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
9.3. Europe
9.3.1. Overview
9.3.2. Semiconductor Memory Key Manufacturers in Europe
9.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
9.3.4. Europe Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
9.3.5. Europe Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
9.3.6. Germany
9.3.6.1. Overview
9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.3.6.3. Germany Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
9.3.6.4. Germany Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
9.3.7. Italy
9.3.7.1. Overview
9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.3.7.3. Italy Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
9.3.7.4. Italy Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
9.3.8. United Kingdom
9.3.8.1. Overview
9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.3.8.3. United Kingdom Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
9.3.8.4. United Kingdom Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
9.3.9. France
9.3.9.1. Overview
9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.3.9.3. France Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
9.3.9.4. France Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
9.3.10. Russia
9.3.10.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.3.10.2. Russia Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
9.3.10.3. Russia Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
9.3.11. Netherlands
9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.3.11.2. Netherlands Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
9.3.11.3. Netherlands Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
9.3.12. Sweden
9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.3.12.2. Sweden Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
9.3.12.3. Sweden Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
9.3.13. Poland
9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.3.13.2. Poland Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
9.3.13.3. Poland Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
9.3.14. Rest of Europe
9.3.14.1. Overview
9.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.3.14.3. Rest of the Europe Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
9.3.14.4. Rest of the Europe Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
9.4. Asia Pacific (APAC)
9.4.1. Overview
9.4.2. Semiconductor Memory Key Manufacturers in Asia Pacific
9.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
9.4.4. Asia Pacific Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
9.4.5. Asia Pacific Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
9.4.6. India
9.4.6.1. Overview
9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.4.6.3. India Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
9.4.6.4. India Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
9.4.7. China
9.4.7.1. Overview
9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.4.7.3. China Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
9.4.7.4. China Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
9.4.8. Japan
9.4.8.1. Overview
9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.4.8.3. Japan Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
9.4.8.4. Japan Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
9.4.9. South Korea
9.4.9.1. Overview
9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.4.9.3. South Korea Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
9.4.9.4. South Korea Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
9.4.10. Australia
9.4.10.1. Overview
9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.4.10.3. Australia Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
9.4.10.4. Australia Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
9.4.11. Thailand
9.4.11.1. Overview
9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.4.11.3. Thailand Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
9.4.11.4. Thailand Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
9.4.12. Indonesia
9.4.12.1. Overview
9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.4.12.3. Indonesia Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
9.4.12.4. Indonesia Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
9.4.13. Philippines
9.4.13.1. Overview
9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.4.13.3. Philippines Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
9.4.13.4. Philippines Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
9.4.14. Rest of APAC
9.4.14.1. Overview
9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.4.14.3. Rest of APAC Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
9.4.14.4. Rest of APAC Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
9.5. Latin America
9.5.1. Overview
9.5.2. Semiconductor Memory Key Manufacturers in Latin America
9.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
9.5.4. Latin America Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
9.5.5. Latin America Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
9.5.6. Brazil
9.5.6.1. Overview
9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.5.6.3. Brazil Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
9.5.6.4. Brazil Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
9.5.7. Mexico
9.5.7.1. Overview
9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.5.7.3. Mexico Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
9.5.7.4. Mexico Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
9.5.8. Argentina
9.5.8.1. Overview
9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.5.8.3. Argentina Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
9.5.8.4. Argentina Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
9.5.9. Colombia
9.5.9.1. Overview
9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.5.9.3. Colombia Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
9.5.9.4. Colombia Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
9.5.10. Rest of LATAM
9.5.10.1. Overview
9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.5.10.3. Rest of LATAM Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
9.5.10.4. Rest of LATAM Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
9.6. Middle East and Africa
9.6.1. Overview
9.6.2. Semiconductor Memory Key Manufacturers in Middle East and Africa
9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
9.6.4. Middle East and Africa Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
9.6.5. Middle East and Africa Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
9.6.6. Saudi Arabia
9.6.6.1. Overview
9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.6.6.3. Saudi Arabia Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
9.6.6.4. Saudi Arabia Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
9.6.7. United Arab Emirates
9.6.7.1. Overview
9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.6.7.3. United Arab Emirates Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
9.6.7.4. United Arab Emirates Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
9.6.8. Israel
9.6.8.1. Overview
9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.6.8.3. Israel Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
9.6.8.4. Israel Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
9.6.9. Turkey
9.6.9.1. Overview
9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.6.9.3. Turkey Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
9.6.9.4. Turkey Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
9.6.10. Algeria
9.6.10.1. Overview
9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.6.10.3. Algeria Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
9.6.10.4. Algeria Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
9.6.11. Egypt
9.6.11.1. Overview
9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.6.11.3. Egypt Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
9.6.11.4. Egypt Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
9.6.12. Rest of MEA
9.6.12.1. Overview
9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.6.12.3. Rest of MEA Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
9.6.12.4. Rest of MEA Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
10. Key Vendor Analysis- Semiconductor Memory Industry
10.1. Competitive Dashboard
10.2. Company Profiles
10.2.1. Vertex Pharmaceuticals
10.2.2. Takeda Pharmaceuticals
10.2.3. Shire (now part of Takeda Pharmaceuticals)
10.2.4. Roche
10.2.5. Pfizer
10.2.6. Novartis
10.2.7. Madrigal Pharmaceuticals
10.2.8. Intercept Pharmaceuticals
10.2.9. Gilead Sciences
10.2.10. Genfit
10.2.11. Durect Corporation
10.2.12. Conatus Pharmaceuticals
10.2.13. Bristol-Myers Squibb
10.2.14. Alnylam Pharmaceuticals
10.2.15. Allergan
11. 360 Degree Analyst View
12. Appendix
12.1. Research Methodology
12.2. References
12.3. Abbreviations
12.4. Disclaimer
12.5. Contact Us
